(5-(4-(4-((3-FLUOROBENZYL)OXY)-3-CHLOROANILINO)-6-QUINAZOLINYL)-2-FURANCARBOXALDEHYDE

UNII:	XA9X87F37H
Formula:	C₂₆H₁₇ClFN₃O₃
Preferred Substance Name:	(5-(4-(4-((3-FLUOROBENZYL)OXY)-3-CHLOROANILINO)-6-QUINAZOLINYL)-2-FURANCARBOXALDEHYDE
InChIKey:	XQPZOUAAXRXPAM-UHFFFAOYSA-N
GSRS Full Record:	XA9X87F37H i

231278-84-5
2-FURANCARBOXALDEHYDE, 5-(4-((3-CHLORO-4-((3-FLUOROPHENYL)METHOXY)PHENYL)AMINO)-6-QUINAZOLINYL)-
5-(4-((3-CHLORO-4-((3-FLUOROBENZYL)OXY)PHENYL)AMINO)QUINAZOLIN-6-YL)FURAN-2-CARBOXALDEHYDE
5-(4-((3-CHLORO-4-((3-FLUOROPHENYL)METHOXY)PHENYL)AMINO)-6-QUINAZOLINYL)-2-FURANCARBOXALDEHYDE
5-(4-(3-CHLORO-4-(3-FLUOROBENZYLOXY)-ANILINO)-6-QUINAZOLINYL)FURAN-2-CARBOXALDEHYDE
LAPATINIB METABOLITE M11

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

(5-(4-(4-((3-FLUOROBENZYL)OXY)-3-CHLOROANILINO)-6-QUINAZOLINYL)-2-FURANCARBOXALDEHYDE

Synonyms and Mappings

Resources